PHARMA & LIFE SCIENCES: LATEST INTERVIEWS MORE INTERVIEWS

“The best way to attract investment is with serious science and well-validated clinical mechanisms of action. An asset in the clinic with a well-described mechanism of action for how it works and peer-reviewed science, including NIH funding, helps with the validity.”
"We are taking a physical supply chain and creating a digital twin of products and data moving through the chain."
"Our focus on capacity utilization, market demand, and strategic acquisitions will be key drivers of TriRx's growth in the coming year."
"Pharma.Aero is a unique collaborative platform connecting life sciences shippers and service providers to achieve reliable end-to-end air transport for pharmaceutical cargo."

PHARMA & LIFE SCIENCES: LATEST ARTICLES

Funding Environment: Life Sciences Enter the Mainstream

April 20, 2021
The past 12 months been transformative for the life science industry in USA, and GBR explores how the funding environment has evolved to provide the influx of capital to sustain its innovations.

Turkey Pharmaceuticals: Bringing All Actors Together

June 17, 2020
Industry, university, investors - the two-way bridge to the knowledge gap.

PHARMA & LIFE SCIENCES: RECENTLY RELEASED PUBLICATIONS

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

Ontario Mining and Toronto's Global Reach 2024 Pre-Release

This pre-release edition of Ontario Mining and Toronto's Global Reach 2024 comprises analysis based on over 40 interviews with the leading executives from major producers, associations, juniors, consultants, investors, and service providers, to provide an in-depth and holistic view of what is happening now, and more pertinently, what could happen in the years ahead.

PARTNER EVENTS